January 20, 2006
Israeli-Developed Sambucol 99% Effective Against Avian Flu
Retroscreen Virology, a medical research institute subsidiary of Queen Mary College, University of London, announced Wednesday that a medical preparation, Sambucol, developed by Israeli company Razei Bar Industries (1996) Ltd., reduced the quantity of cells infected with the H5N1 strain of avian flu virus by 99%.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment